The Effect of Alemtuzumab on the Blood-brain-barrier and the Brain's Metabolism in Multiple Sclerosis Patients

NCT03193086 · clinicaltrials.gov ↗

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Alemtuzumab

Sponsor

Glostrup University Hospital, Copenhagen

Collaborators

[object Object]